Atlas Merchant Capital’s DA32 Life Science Tech Acquisition Corp. Class A Common Stock DALS Stock Holding History

Atlas Merchant Capital’s Portfolio DALS Stock Details DALS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-247,193	Closed	-$2.54M	–	130
2023 Q2	$2.54M	Hold	247,193	–	–	0.46%	61
2023 Q1	$2.5M	Hold	247,193	–	–	0.38%	73
2022 Q4	$2.47M	Buy	+247,193	New	+$2.43M	0.4%	87

Atlas Merchant Capital's DALS Position: Q3 2023 in Review

Atlas Merchant Capital sold out of DA32 Life Science Tech Acquisition Corp. Class A Common Stock (DALS) in Q3 2023, closing a stake of 247,193 shares — an estimated $2.54M sold.

Atlas Merchant Capital first reported a position in DALS in Q4 2022 and held it in 3 quarters. The position peaked at $2.54M in Q2 2023. 0 funds tracked by Wall St. Rank hold DALS as of Q3 2023.

Atlas Merchant Capital reported no remaining DA32 Life Science Tech Acquisition Corp. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
Atlas Merchant Capital sold 247,193 DA32 Life Science Tech Acquisition Corp. Class A Common Stock shares in Q3 2023, an estimated $2.54M.
Atlas Merchant Capital first reported a position in DA32 Life Science Tech Acquisition Corp. Class A Common Stock in Q4 2022 and held it in 3 quarters.
Atlas Merchant Capital's DA32 Life Science Tech Acquisition Corp. Class A Common Stock position peaked at $2.54M in Q2 2023.
0 funds tracked by Wall St. Rank held DA32 Life Science Tech Acquisition Corp. Class A Common Stock as of Q3 2023.

Based on Atlas Merchant Capital's 13F filing for Q3 2023, filed 14 Nov 2023.